Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients von Balloy, G., Pelletier, J., Suchet, L., Lebrun, C., Cohen, M., Vermersch, P., Zephir, H., Duhin, E., Gout, O., Deschamps, R., Le Page, E., Edan, G., Labauge, P., Carra-Dallieres, C., Rumbach, L., Berger, E., Lejeune, P., Devos, P., N’Kendjuo, J.-B., Coustans, M., Auffray-Calvier, E., Daumas-Duport, B., Michel, L., Lefrere, F., Laplaud, D. A., Brosset, C., Derkinderen, P., de Seze, J., Wiertlewski, S.

Volltext

SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis von Lejeune, F., Chatton, A., Laplaud, D.-A., Le Page, E., Wiertlewski, S., Edan, G., Kerbrat, A., Veillard, D., Hamonic, S., Jousset, N., Le Frère, F., Ouallet, J.-C., Brochet, B., Ruet, A., Foucher, Y., Michel, Laure

Volltext

Natalizumab and drug holiday in clinical practice: An observational study in very active relapsing remitting Multiple Sclerosis patients von Kerbrat, A, Le Page, E, Leray, E, Anani, T, Coustans, M, Desormeaux, C, Guiziou, C, Kassiotis, P, Lallement, F, Laplaud, D, Diraison, P, Rouhart, F, Sartori, E, Wardi, R, Wiertlewski, S, Edan, G

Volltext

Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort von Lebrun, C, Le Page, E, Kantarci, O, Siva, A, Pelletier, D, Okuda, DT

Volltext

Evidence for a two-stage disability progression in multiple sclerosis von Leray, Emmanuelle, Yaouanq, Jacqueline, Le Page, Emmanuelle, Coustans, Marc, Laplaud, David, Oger, Joël, Edan, Gilles

Volltext

Elderly onset neuromyelitis optica spectrum disorder: a case report von Leguy, S., Le Page, E., Drapier, S.

Volltext

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis von Ghalie, R G, Mauch, E, Edan, G, Hartung, H P, Gonsette, R E, Eisenmann, S, Le Page, E, Butine, M D, Goodkin, D E

Volltext

Induction or escalation therapy for patients with multiple sclerosis? von Le Page, E., Edan, G.

Volltext

Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis? von Bonenfant, J., Bajeux, E., Deburghgraeve, V., Le Page, E., Edan, G., Kerbrat, A.

Volltext

Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial von Edan, G, Comi, G, Le Page, E, Leray, E, Rocca, M A, Filippi, M

Volltext

Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient von Hay, M., Leguy, S., Cahagne, V., Lassalle, N., Le Page, E., Michel, L.

Volltext

Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study von Leblanc, S., Roux, J., Tillaut, H., Le Page, E., Leray, E.

Volltext

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study von Le Page, E, Leray, E, Edan, G

Volltext

Ten-year follow-up after mitoxantrone induction for early highly active relapsing-remitting multiple sclerosis: An observational study of 100 consecutive patients von Lefort, M., Le Corre, G., Le Page, E., Rizzato, C., Le Port, D., Michel, L., Kerbrat, A., Leray, E., Edan, G.

Volltext

The window of therapeutic opportunity in multiple sclerosis : Evidence from monoclonal antibody therapy von COLES, Alasdair J, COX, Amanda, COMPSTON, D. Alastair, LE PAGE, Emmanuelle, JONES, Joanne, TRIP, S. Anand, DEANS, Jackie, SEAMAN, Shaun, MILLER, David H, HALE, Geoff, WALDMANN, Herman

Volltext

Prior suggestive symptoms in one-third of patients consulting for a “first” demyelinating event von Gout, O, Lebrun-Frenay, C, Labauge, P, Le Page, G E, Clavelou, P, Allouche, S

Volltext

Neuromyelitis optica in France: A multicenter study of 125 patients von COLLONGUES, N, MARIGNIER, R, FONTAINE, B, BRASSAT, D, CLANET, M, MILH, M, PELLETIER, J, AUDOIN, B, RUET, A, LEBRUN-FRENAY, C, THOUVENOT, E, CAMU, W, ZEPHIR, H, DEBOUVERIE, M, CREANGE, A, MOREAU, T, LABAUGE, P, CASTELNOVO, G, EDAN, G, LE PAGE, E, DEFER, G, BARROSO, B, HEINZLEF, O, PAPEIX, C, GOUT, O, RODRIGUEZ, D, WIERTLEWSKI, S, LAPLAUD, D, BORGEL, F, TOURNIAIRE, P, GRIMAUD, J, BROCHET, B, VERMERSCH, P, CONFAVREUX, C, BLANC, F, DE SEZE, J, RITLENG, C, TCHIKVILADZE, M, OUTTERYCK, O, VUKUSIC, S, FLEURY, M

Volltext

Developing tools to evaluate quality of care management for patients living with multiple sclerosis: An original French initiative von Veillard, D., Deburghgraeve, V., Le Page, E., Debouverie, M., Wiertlewski, S., Gallien, P., Edan, G.

Volltext

Evaluation of the quality of the care pathway for patients with multiple sclerosis in France: Results of an original study of a cohort of 700 patients von Veillard, D., Le Page, E., Epstein, J., Wiertlewski, S., Gallien, P., Hamonic, S., Debouverie, M., Edan, G.

Volltext

Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial von Michel, M., Le Page, E., Laplaud, D.A., Wardi, R., Lebrun, C., Zagnoli, F., Wiertlewski, S., Coustans, M., Edan, G., Chevreul, K., Veillard, D., Lallement, F., Cohen, M., Blanchard, C., Sartori, E., Demarco, O., Rouhart, F., Papeix, C., Taurin, G., Anani, T., Kassiotis, P., Hamon, C., Lester, M.A., Merienne, M.

Volltext